The US and Ukraine have signed an “economic partnership agreement,” while a bipartisan attempt to rebuke President Donald ...

T. Rowe Price has struggled with turning the ship around in terms of the AUM outflows, with 13 quarters of AUM outflows. Read ...

Discover phases of acute ischemic stroke care, from rapid recognition to long-term recovery strategies that neurologists use ...

Red light therapy is linked to a range of benefits, including improved skin health and reduced inflammation, but the science ...

Q1 2025 Earnings Call Transcript April 29, 2025 Option Care Health, Inc. misses on earnings expectations. Reported EPS is ...

Fresenius Medical Care offers strong credit, a solid pipeline, but weak margins and limited short-term upside curb enthusiasm ...

A strong onboarding process can help your physician career get off to the right start. Here is what to expect—and what to ask for.

Accurate patient flow forecasting enables pharmaceutical companies ... Reducing clinical trial costs is a vital step in making cutting-edge treatments more accessible. Clinical trials are ...

Phase 2 data featured in an oral presentation at the American Academy of Neurology Annual Meeting ATH434-202 open-label trial in advanced MSA completed in March 2025 Cash balance on 31 March 2025 of ...

Jennifer Halchak; VP, IR; Organon & Co. Kevin Ali; Chief Executive Officer, Director; Organon & Co. Matthew Walsh; Chief Financial Officer, Senior Vice President; Or ...

Q1 2025 Earnings Call Transcript April 24, 2025 Gentherm Incorporated beats earnings expectations. Reported EPS is $0.51, ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...